Quinoline derivatives as neurokinin receptor antagonists

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 215/52 (2006.01) A61K 31/47 (2006.01) A61P 25/18 (2006.01)

Patent

CA 2575697

The present invention relates to compounds of Formula (I) and their pharmaceutically acceptable salts, pharmaceutical compositions comprising them and their use in treating diseases mediated by neurokinin-2 and/or neurokinin- 3 (NK-3) receptors, such as schizophrenia.

La présente invention concerne des composés représentés par la formule (I) et leurs sels pharmaceutiquement acceptables, les compositions pharmaceutiques qui les contiennent et leur utilisation dans le traitement des maladies induites par les récepteurs de la neurokinine-2 et/ou neurokinine-3 (NK-3), telle que la schizophrénie.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Quinoline derivatives as neurokinin receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Quinoline derivatives as neurokinin receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinoline derivatives as neurokinin receptor antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2078204

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.